Brachytherapy
Volume 7, Issue 2 , Pages 92-93, April 2008

High-dose-rate brachytherapy as monotherapy for favorable-risk prostate cancer. Improved toxicity profile with real-time transrectal ultrasound 3D vs 2D treatment planning and dosimetry

Radiation Oncology, William Beaumont Hospital, Royal Oak, MI

OR2 Presentation Time: 3:10 PM

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(08)00394-2

doi:10.1016/j.brachy.2008.02.338

Brachytherapy
Volume 7, Issue 2 , Pages 92-93, April 2008

Article Tools